{"organizations": [], "uuid": "0d53737e84eb2bf97abeb2f55282a1625726f5fb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biomed-lublin-adopts-strategy-for/brief-biomed-lublin-adopts-strategy-for-2018-2022-idUSFWN1S1071", "country": "US", "domain_rank": 408, "title": "BRIEF-Biomed Lublin Adopts Strategy For 2018-2022", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-04-24T14:17:00.000+03:00", "replies_count": 0, "uuid": "0d53737e84eb2bf97abeb2f55282a1625726f5fb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biomed-lublin-adopts-strategy-for/brief-biomed-lublin-adopts-strategy-for-2018-2022-idUSFWN1S1071", "ord_in_thread": 0, "title": "BRIEF-Biomed Lublin Adopts Strategy For 2018-2022", "locations": [], "entities": {"persons": [{"name": "biomed lublin", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " BIOMED LUBLIN WYTWORNIA SUROWIC I SZCZEPIONEK SA:\n* ADOPTS STRATEGY 2018-2022\n* PLANS TO INVEST IN CONSTRUCTION OF NEW PRODUCTION PLANT * IDENTIFIES THREE STRATEGIC PRODUCTS: ONKO BCG, ANTI-TUBERCULOSIS VACCINE BCG AND DISTREPTAZA\n* CONSTRUCTION OF NEW PRODUCTION PLANT WILL ALLOW TO INCREASE PRODUCTION VOLUME OF STRATEGIC PRODUCTS\n* SEES YEARLY REVENUE EXCEEDING 100 MILLION ZLOTYS AFTER IMPLEMENTATION OF STRATEGIC PLANS\n* ESTIMATES INVESTMENT COSTS AT ABOUT 150 MILLION ZLOTYS, PLANS TO GET 60% OF FINANCING FROM EU SUBSIDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-24T14:17:00.000+03:00", "crawled": "2018-04-25T14:13:33.052+03:00", "highlightTitle": ""}